Annual Drug Patent Expirations for ANGIOMAX+RTU
Angiomax Rtu is a drug marketed by Maia Pharms Inc and is included in one NDA. It is available from three suppliers. There are two patents protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in ANGIOMAX RTU is bivalirudin. Three suppliers are listed for this compound. Additional details are available on the bivalirudin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
